Latest / Stock Movers / Genmab Gains, Sabadell Rises, Vend Tumbles
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios.
- 0:04Speaker 2: Podcasts. Radio.
- 0:06Speaker 3: News.
- 0:08Speaker 2: The Stock Movers Report. Your roundup of companies making moves
- 0:12Speaker 2: in the stock market. Harnessing the power of Bloomberg data.
- 0:16Speaker 2: Let's take a look at some stocks on the move
- 0:18Speaker 2: today in Europe. I'm Jason Wilcock and we're joined by
- 0:20Speaker 2: Caroline Hepka. And we have in the studio Bloomberg reporter
- 0:24Speaker 2: Tiwa Adebayo. Tiwa, let's start with the biotech firm GenMap. Yes.
- 0:29Speaker 3: So, they're gaining as much as 8.7% today. And that's
- 0:34Speaker 3: after they posted the latest data for their lymphoma drug.
- 0:37Speaker 1: That's really impressed analysts.
- 0:39Speaker 3: So, they're at their highest stock price level since September 2023.
- 0:45Speaker 3: This is because their drug has cut the risk of
- 0:49Speaker 3: disease progression or death. It's been found to do that,
- 0:52Speaker 3: to cut that by 51%. That's according to Phase 3
- 0:56Speaker 3: top-line data. We also saw their shares gaining yesterday, actually,
- 1:00Speaker 3: after they released Phase 2 data for a drug which
- 1:04Speaker 3: treats ovarian cancer. So, a good couple of days for
- 1:08Speaker 3: their research and their drug production. But analysts are saying
- 1:12Speaker 3: these positive results are helping to de-risk sales expectations with
- 1:17Speaker 3: progression-free survival rate ahead of what they expected yesterday. So,
- 1:22Speaker 3: that's what's driving shares up at GenMav this morning.
- 1:25Speaker 4: Okay.
- 1:25Speaker 1: So, that on GenMav.
- 1:26Speaker 4: Meanwhile, Sabadell, the bank, there's a group that has taken
- 1:32Speaker 4: a stake in it, but it's about what that means
- 1:35Speaker 4: for Sabadell, isn't it?
- 1:37Speaker 2: Yeah.
- 1:37Speaker 3: So, their shares are up this morning as much as
- 1:40Speaker 3: about 3.3%. And as you mentioned, the French banking group
- 1:43Speaker 3: BPCE has acquired a stake of about 7%. And this
- 1:48Speaker 3: is because the CEO of BPCE is seeking to expand
- 1:54Speaker 3: the business outside of the French banking home market. It
- 1:57Speaker 3: said that this investment is of a friendly nature and
- 2:00Speaker 3: the goal is to explore strategic cooperation. That's according to
- 2:05Speaker 3: a joint statement from the two firms today. We'll expect
- 2:10Speaker 3: BPCE to have board representation.
- 2:13Speaker 1: But it has pledged to keep the stake below 10%.
- 2:15Speaker 3: It will make the French lender the second largest shareholder
- 2:20Speaker 3: in Sabadell. That's after BlackRock, according to data. But it
- 2:24Speaker 3: is this next move to expand the business. But for Sabadell,
- 2:28Speaker 3: it means it's getting another large shareholder interested in its
- 2:32Speaker 3: distribution capabilities. It also counts Zurich Insurance Group among its investors.
- 2:39Speaker 1: So, it's good news for Sabadar. Hence, we're seeing their
- 2:41Speaker 1: share price up.
- 2:42Speaker 4: Yeah. BPCE, you may know by the sort of high
- 2:47Speaker 4: street names. This is the Caisse de Pannier. They've also
- 2:50Speaker 4: got the Banque Populaire. They've got Credit Co-op IT for
- 2:54Speaker 4: Novo Banco. They've got lots of different brands, but all
- 2:57Speaker 4: under that umbrella group of that name.
- 3:00Speaker 1: Well, Tia, what else are you watching on the equity
- 3:01Speaker 1: markets this morning?
- 3:03Speaker 3: Vend Marketplaces, the major Northern European digital marketplace company, their
- 3:09Speaker 3: shares have tumbled as much as 10%. And this is
- 3:12Speaker 3: after a downgrade that we've seen this morning from Nordea.
- 3:15Speaker 3: They've downgraded to sell from buy. And this is about
- 3:20Speaker 3: AI risk. They see a risk of consumers using AI
- 3:24Speaker 3: to access inventory. And that could cause the platform to
- 3:27Speaker 3: lose control of traffic and also monetization. So, analysts saying
- 3:32Speaker 3: that the AI threat has now moved from a theoretical
- 3:35Speaker 3: risk to an emerging reality. So, they've cut their EBITDA
- 3:40Speaker 3: expectations by around 7% to 12%. So, this is causing
- 3:46Speaker 3: shares really to tumble this morning for Venn marketplaces.
- 3:50Speaker 2: The Stock Movers Report from Bloomberg Radio. Check back with
- 3:54Speaker 2: us throughout the day for the latest roundup of companies
- 3:57Speaker 2: making news on Wall Street. And for the latest market-moving headlines,
- 4:01Speaker 2: listen to Bloomberg Radio live. Catch us on YouTube, Bloomberg.com,
- 4:06Speaker 2: and on Apple CarPlay and Android Auto with the Bloomberg
- 4:09Speaker 2: Business app.